Biomarker-directed aptamer panels for diagnosis and staging in gastrointestinal cancers and steatotic liver disease

Investigations of biomarker-directed aptamer panels in individuals with metabolic dysfunction-associated steatotic liver diseasen, hepatocellular carcinoma and neuroendocrine tumors of the small intestine and the pancreas.